NO166940C - Analogifremgangsmaate for fremstilling av terapeutisk aktive 4 (5)-substituerte imidazol-derivater, og mellomprodukttil bruk ved fremstillingen. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive 4 (5)-substituerte imidazol-derivater, og mellomprodukttil bruk ved fremstillingen.

Info

Publication number
NO166940C
NO166940C NO872004A NO872004A NO166940C NO 166940 C NO166940 C NO 166940C NO 872004 A NO872004 A NO 872004A NO 872004 A NO872004 A NO 872004A NO 166940 C NO166940 C NO 166940C
Authority
NO
Norway
Prior art keywords
preparation
lower alkyl
imidazole derivatives
alkyl
substituted imidazole
Prior art date
Application number
NO872004A
Other languages
English (en)
Norwegian (no)
Other versions
NO166940B (no
NO872004D0 (no
NO872004L (no
Inventor
Arja Leena Karjalainen
Arto Johannes Karjalainen
Original Assignee
Farmos Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FI862039A external-priority patent/FI862039A0/fi
Priority claimed from FI870462A external-priority patent/FI870462A0/fi
Application filed by Farmos Oy filed Critical Farmos Oy
Publication of NO872004D0 publication Critical patent/NO872004D0/no
Publication of NO872004L publication Critical patent/NO872004L/no
Priority to NO882728A priority Critical patent/NO167735C/no
Publication of NO166940B publication Critical patent/NO166940B/no
Publication of NO166940C publication Critical patent/NO166940C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/58—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Golf Clubs (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Dental Preparations (AREA)
  • Epoxy Resins (AREA)
NO872004A 1986-05-15 1987-05-14 Analogifremgangsmaate for fremstilling av terapeutisk aktive 4 (5)-substituerte imidazol-derivater, og mellomprodukttil bruk ved fremstillingen. NO166940C (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO882728A NO167735C (no) 1986-05-15 1988-06-21 Analogifremgangsmaate for fremstilling av terapeutisk aktive 4(5)-substituerte imidazol-derivater.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI862039A FI862039A0 (fi) 1986-05-15 1986-05-15 Nytt foerfarande foer framstaellning av 4(5)-substituerade imidazolderivat.
FI870462A FI870462A0 (fi) 1987-02-04 1987-02-04 Foerfarande foer framstaellning av 4(5)-substituerade imidazolderivat.

Publications (4)

Publication Number Publication Date
NO872004D0 NO872004D0 (no) 1987-05-14
NO872004L NO872004L (no) 1987-11-16
NO166940B NO166940B (no) 1991-06-10
NO166940C true NO166940C (no) 1991-09-25

Family

ID=26157963

Family Applications (1)

Application Number Title Priority Date Filing Date
NO872004A NO166940C (no) 1986-05-15 1987-05-14 Analogifremgangsmaate for fremstilling av terapeutisk aktive 4 (5)-substituerte imidazol-derivater, og mellomprodukttil bruk ved fremstillingen.

Country Status (18)

Country Link
US (2) US4933359A (de)
EP (1) EP0247764B1 (de)
JP (1) JP2561272B2 (de)
KR (1) KR950002158B1 (de)
AT (1) ATE66211T1 (de)
AU (1) AU600725B2 (de)
CA (1) CA1299186C (de)
DE (1) DE3772104D1 (de)
DK (1) DK172422B1 (de)
ES (1) ES2037712T3 (de)
FI (1) FI81092C (de)
GR (1) GR3002928T3 (de)
HU (1) HU197314B (de)
IE (1) IE59609B1 (de)
IL (1) IL82541A (de)
NO (1) NO166940C (de)
NZ (1) NZ220306A (de)
PT (1) PT84881B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2225782A (en) * 1988-12-09 1990-06-13 Farmos Group Limited Imidazole derivatives useful for treatment of diabetes
CA1321751C (en) * 1989-02-21 1993-08-31 Eugene C. Crichlow Mechanism mediating ruminal stasis in ruminal lactic acidosis
GB2244431A (en) * 1990-05-31 1991-12-04 Farmos Oy Treatment of age related memory impairment and other cognitive disorders
FR2669030B1 (fr) * 1990-11-14 1992-12-31 Adir Nouveaux derives d'imidazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
GB9127050D0 (en) * 1991-12-20 1992-02-19 Orion Yhtymae Oy Substituted imidazole derivatives and their preparation and use
GB9312669D0 (en) 1993-06-18 1993-08-04 Orion Yhtymae Oy New opticla isomers
FR2735776B1 (fr) * 1995-06-22 1997-07-18 Synthelabo Derives de 2,3-dihydro-1h-indole, leur preparation et leur application en therapeutique
GB9520150D0 (en) * 1995-10-03 1995-12-06 Orion Yhtymae Oy New imidazole derivatives
JP2002534511A (ja) * 1999-01-18 2002-10-15 ノボ ノルディスク アクティーゼルスカブ 置換型イミダゾール、それらの調製及び使用
US6388090B2 (en) * 2000-01-14 2002-05-14 Orion Corporation Imidazole derivatives
CA2408290A1 (en) * 2000-05-08 2001-11-15 Orion Corporation New polycyclic indanylimidazoles with alpha2 adrenergic activity
US8188126B2 (en) 2002-05-16 2012-05-29 Pierre Fabre Medicament Imidazolic compounds and use thereof as alpha-2 adrenergic receptors
FR2839719B1 (fr) * 2002-05-16 2004-08-06 Pf Medicament Nouveaux composes imidazoliques, leur procede de preparation et leur utilisation a titre de medicaments
WO2007025383A1 (en) * 2005-08-30 2007-03-08 Queen's University At Kingston Potentiation of the therapeutic action of an opioid receptor agonist and/or inhibition or reversal of tolerance to an opioid receptoi agonists using an ultralow dose of an alpha-2 receptor antagonist
CL2008003553A1 (es) * 2007-12-05 2009-11-27 Grindeks Jsc Proceso para preparar atipamezol o clorhidrato de 5-(2-etil-2,3-dihidro-1h-inden-2-il)-1h-imidazol: y loa compuestos intermediarios considerados en el proceso
WO2011009928A1 (en) * 2009-07-24 2011-01-27 Dsm Pharma Chemicals Regensburg Gmbh Indane derivatives for use as intermediates

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7908922A (nl) * 1979-12-12 1981-07-16 Akzo Nv Carboximidamide derivaten.
US4480118A (en) * 1981-01-13 1984-10-30 Sumitomo Chemical Company, Limited Carboxylic acid ester and an insecticidal and/or acaricidal composition containing the same
ATE19621T1 (de) * 1981-09-15 1986-05-15 Ici Plc Aminosubstituierte tetraline und verwandte homocyclische verbindungen.
US4661522A (en) * 1984-05-24 1987-04-28 Akzo N.V. Cycloalkane-indene-carboximidamide derivatives
GB2167408B (en) * 1984-11-23 1988-05-25 Farmos Oy Substituted imidazole derivatives and their preparation and use

Also Published As

Publication number Publication date
GR3002928T3 (en) 1993-01-25
JPS62289566A (ja) 1987-12-16
IE59609B1 (en) 1994-03-09
IL82541A (en) 1992-06-21
ES2037712T3 (es) 1993-07-01
FI871655A0 (fi) 1987-04-15
IL82541A0 (en) 1987-11-30
DE3772104D1 (de) 1991-09-19
US5026868A (en) 1991-06-25
KR950002158B1 (ko) 1995-03-14
KR880009941A (ko) 1988-10-06
NZ220306A (en) 1990-02-26
NO166940B (no) 1991-06-10
AU600725B2 (en) 1990-08-23
FI81092C (fi) 1990-09-10
PT84881B (pt) 1990-02-08
US4933359A (en) 1990-06-12
FI871655A (fi) 1987-11-16
DK172422B1 (da) 1998-06-08
ATE66211T1 (de) 1991-08-15
HU197314B (en) 1989-03-28
AU7310287A (en) 1987-11-19
HUT45234A (en) 1988-06-28
CA1299186C (en) 1992-04-21
IE871258L (en) 1987-11-15
NO872004D0 (no) 1987-05-14
EP0247764A1 (de) 1987-12-02
FI81092B (fi) 1990-05-31
PT84881A (en) 1987-06-01
EP0247764B1 (de) 1991-08-14
JP2561272B2 (ja) 1996-12-04
DK208287D0 (da) 1987-04-24
NO872004L (no) 1987-11-16
DK208287A (da) 1987-11-16

Similar Documents

Publication Publication Date Title
NO166940C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4 (5)-substituerte imidazol-derivater, og mellomprodukttil bruk ved fremstillingen.
ES2150353A1 (es) Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos.
HU207853B (en) Process for producing pyrimidine-4,6-dicarboxylic acid-diamides
EE200000504A (et) Bensofurüül-a-pürooni derivaadid, farmatseutilinekompositsioon, lipiidide ainevahetuse kiirendaja,triglütseriidi biosünteesi inhibiitor, vere triglütseriiditaset alandav toimeaine, vere HDL taset tõstev toimeaine, arterioskleroosi profülaktiline to
NO168582C (no) Analogifremgangsmaate for fremstilling av nye, terapeutiskvirksomme dihydrobenzofuran- og chroman-carboxamidderivater
FI942882A (fi) Substituoituja imidatsolijohdannaisia ja niiden valmistus ja käyttö
DE69110828D1 (de) Heterozyklische Aminderivate, deren Herstellung und deren Verwendung.
US4652565A (en) Piperazine derivatives, their production and pharmaceutical compositions containing them
ATE90348T1 (de) Pyrido(2,3-d>pyrimidin-derivate.
NO162421C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylinderivater og syreaddisjonssalter derav.
AP9801410A0 (en) Indoline derivatives useful as 5-HT-2C receptor antagonists.
DE3883891D1 (de) Benzimidazol-Derivate und Verfahren zu deren Herstellung.
FI103885B1 (fi) Menetelmä terapeuttisesti aktiivisten 1-bentsyyli-4-fenyylipiperatsiinijohdannaisten valmistamiseksi ja välituotteina käyttökelpoisia yhdisteitä
NZ240298A (en) 4-(4- and/or 6-(trifluoromethyl)pyrid-2-)piperazin-1-ylalkyl substituted lactam derivatives
ATE9896T1 (de) Substituierte 3-aryl-2-cycloalken-1-one, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
PT92175A (pt) Processo para a preparacao de 3-amino-sidnoniminas substituidas e de produtos intermediarios farmacologicamente activos